NovoCure Limited
US ˙ NasdaqGS ˙ JE00BYSS4X48

SecurityNVCR / NovoCure Limited
InstitutionAllworth Financial LP
Latest Disclosed Ownership965 shares
Latest Disclosed Value $ 10,519
Allworth Financial LP reports 35.92% increase in ownership of NVCR / NovoCure Limited

On May 14, 2026 - Allworth Financial LP filed a 13F-HR form disclosing ownership of 965 shares of NovoCure Limited (US:NVCR) valued at $10,518 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 710 shares of NovoCure Limited. This represents a change in shares of 35.92% during the quarter. The current value of the position is $17,360 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVOCURE ORD SHS G6674U108 965 255 35.92 11 11.11 0.0000
2026-02-05 2025-12-31 13F NOVOCURE ORD SHS G6674U108 710 -254 -26.35 9 -25.00 0.0000
2025-12-02 2025-09-30 13F NOVOCURE ORD SHS G6674U108 964 328 51.57 12 9.09 0.0001
2025-08-07 2025-06-30 13F NOVOCURE ORD SHS G6674U108 636 300 89.29 11 83.33 0.0001
2025-04-30 2025-03-31 13F NOVOCURE ORD SHS G6674U108 336 -92 -21.50 6 -45.45 0.0000
2025-01-30 2024-12-31 13F NOVOCURE ORD SHS G6674U108 428 7 1.66 11 83.33 0.0001
2024-10-23 2024-09-30 13F NOVOCURE ORD SHS G6674U108 421 -25 -5.61 7 -25.00 0.0000
2024-07-24 2024-06-30 13F NOVOCURE ORD SHS G6674U108 446 -602 -57.44 8 -50.00 0.0001
2024-04-25 2024-03-31 13F NOVOCURE ORD SHS G6674U108 1,048 -25 -2.33 16 0.00 0.0001
2024-01-24 2023-12-31 13F NOVOCURE ORD SHS G6674U108 1,073 929 645.14 16 700.00 0.0001
2023-10-31 2023-09-30 13F NOVOCURE ORD SHS G6674U108 144 144 2 0.0000
2023-07-18 2023-06-30 13F NOVOCURE ORD SHS G6674U108 0 -33 -100.00 0 -100.00
2023-04-18 2023-03-31 13F NOVOCURE ORD SHS G6674U108 33 -185 -84.86 2 -93.33 0.0000
2023-01-13 2022-12-31 13F NOVOCURE ORD SHS G6674U108 218 -19 -8.02 16 -16.67 0.0002
2022-11-14 2022-09-30 13F/A-1 NOVOCURE ORD SHS G6674U108 237 28 13.40 18 20.00 0.0002
2022-10-18 2022-09-30 13F NOVOCURE ORD SHS G6674U108 237 28 18 0.0002
2022-07-13 2022-06-30 13F NOVOCURE ORD SHS G6674U108 209 206 6,866.67 15 0.0002
2022-04-22 2022-03-31 13F NOVOCURE ORD SHS G6674U108 3 -186 -98.41 0 -100.00
2022-01-21 2021-12-31 13F NOVOCURE ORD SHS G6674U108 189 105 125.00 14 40.00 0.0002
2021-11-02 2021-09-30 13F NOVOCURE ORD SHS G6674U108 84 84 10 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.